1548 — Genscript Biotech Share News
0.000.00%
Last trade - 00:00- HK$76.05bn
- HK$72.43bn
- $959.53m
Brief: Genscript Biotech Says Unit Announced Japan's Ministry Of Health, Labour & Welfare Has Approved Carvykti
Brief: Genscript And Gladstone-Ucsf Institute Of Genomic Immunology Collaborate On Non-Viral Cell Therapy Study
Brief: Genscript Biotech Reports HY Revenue Increasing 32.7%
Brief: GenScript USA Responds To Monkeypox Public-Health Emergency With Real-Time PCR Test
Legend Biotech prices upsized $350 mln equity offering
Legend Biotech drops on $250 mln stock offering plans
Brief: Genscript Biotech Says On 27 June Genscript Jiangsu, Probio Jiangsu And Others Entered Into Properties Purchase Agreements
Brief: Genscript USA Enters Distribution Agreement With Euroimmun US For Cpass Sars-CoV-2 Neutralizing Antibody Detection Kit
Brief: Genscript Biotech Says Committee For Medicinal Products Human Use Of European Medicines Agency Recommended Marketing Authorization Of Carvykti
Brief: Genscript Biotech Sees An Adjusted Loss Of Us$290.4 Million To Us$316.2 Million For Year
Brief: Genscript Biotech Says Legend Biotech Corp On 11 Feb Was Informed By U.S. FDA Its Phase 1 Clinical Trial For Lb1901 Has Been Placed On Clinical Hold
Legend Biotech slides after pricing equity offering
Legend Biotech eyes worst day after launching $300 mln equity offering
Brief: Genscript Biotech' Unit Submits NDA To Japanese Ministry Of Health, Labour And Welfare
HK's Genscript Biotech jumps on deal to commercialize COVID-19 mRNA vaccine
Brief: Genscript Biotech Announces Cooperation On Biologic License Application Of mRna Vaccines
Brief: Genscript Biotech Posts HY Adjusted Net Loss Of About US$134.3 Million
Brief: Genscript Biotech Says Probio Cayman Agreed To Sell And Issue Total Of 300 Mln Series A Preferred Shares For About US$150 Mln
Brief: GenScript Announces Notice Of Allowance For U.S. Patent Application For SARS-CoV-2 Surrogate Virus Neutralization Kit